HIV Treatment Experienced Attachment Inhibitor Study
The purpose of this study is to determine if an investigational treatment regimen of BMS-663068 (BMS Attachment Inhibitor) twice a day, plus other antiretroviral medications used in combination is safe and effective for the treatment of subjects who are infected with Human Immunodeficiency Virus (HIV-1). HIV positive subjects in this research study must be "Heavily Treatment Experienced". This means you must have taken many HIV medications during the history of your disease.
Who may be Eligible
Adult patients with HIV who are failing their current regimen and have less than or equal to 2 classes of medications available to them; Participants must agree to protocol defined birth control methods during the study; Subjects will need to have normal maintenance labs and EKG resutls as defined by the study parameters.